idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
MHH researchers are developing bioreactors to produce millions of human immune cells. The method opens up new opportunities for research and treatment.
Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such as macrophages, in medium-sized bioreactors. These immune cells can be derived from induced pluripotent stem cells and are important for disease research and the development of new therapeutic approaches. The method has now been published in the journal Nature Protocols.
Macrophages – also known as ‘scavenger cells’ – play a central role in the human immune system. They are indispensable for defending against pathogens and for repairing damaged tissue. Furthermore, they are already being used in clinical therapy, for example in the treatment of liver diseases. Scientists are also investigating further potential applications – including for the treatment of infectious diseases, inflammation, fibrosis and cancer, as well as neurodegenerative diseases such as Alzheimer’s. Macrophages are also suitable for testing drugs for purity, safety and efficacy.
Efficient, cost-effective and easy to use: the new bioreactors
For research purposes, macrophages can be produced from so-called induced pluripotent stem cells (iPS cells). These are somatic cells that have been ‘reprogrammed’ using biotechnology and from which, in principle, any type of cell in the body can develop. Until now, macrophages have mostly been produced either on a small scale for laboratory studies or on a large scale for industrial applications. Medium-sized bioreactors, which are particularly well suited to preclinical research projects because they are efficient, cost-effective and easy to handle, have been virtually non-existent until now.
A team led by Prof. Dr. Nico Lachmann from the Department of Paediatric Pneumology, Allergology and Neonatology at Hannover Medical School (MHH) has now developed a technique for such bioreactors. The corresponding publication appeared in the journal Nature Protocols. The first author is Dr. Fawaz Saleh.
A valuable tool for science
Using the new method, iPS cells continue to differentiate in a culture medium and form cell aggregates, known as organoids, within 14 days. These structures, which resemble haematopoietic bone marrow, subsequently release macrophages on a continuous basis: “We can harvest up to 40 million immune cells per bioreactor every week over a period of ten weeks,” says Professor Lachmann. Four bioreactors are combined in a single device. The technology developed thus offers a valuable tool for research into human immune cells and their medical applications.
Prof. Lachmann conducts research in the RESIST Cluster of Excellence and at the Research Centre for Translational Regenerative Medicine, amongst other places. For his work, he has been awarded an ERC Starting Grant and two Proof-of-Concept Grants by the European Union.
SERVICE
For more information, please contact Prof. Dr. Nico Lachmann, Lachmann.Nico@mh-hannover.de.
You can find the original publication “Harnessing intermediate-scale bioreactors for next-generation macrophage production and application” here: https://www.nature.com/articles/s41596-025-01313-x
Dr. Fawaz Saleh from the Department of Paediatric Pneumology, Allergology and Neonatology at Hannove ...
Copyright: Karin Kaiser/MHH
The white cell clusters in the red culture medium produce macrophages (phagocytes).
Copyright: Karin Kaiser/MHH
Merkmale dieser Pressemitteilung:
Journalisten
Medizin
überregional
Forschungsergebnisse, Wissenschaftliche Publikationen
Englisch
Dr. Fawaz Saleh from the Department of Paediatric Pneumology, Allergology and Neonatology at Hannove ...
Copyright: Karin Kaiser/MHH
The white cell clusters in the red culture medium produce macrophages (phagocytes).
Copyright: Karin Kaiser/MHH
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
